Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-25 @ 10:41 PM
NCT ID: NCT01786967
Description: None
Frequency Threshold: 5
Time Frame: 4 weeks
Study: NCT01786967
Study Brief: Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Poor Metabolizers Poor metabolizer status was based on CYP2D6 sequence 0 None 0 4 0 4 View
Metabolizer Status Undetermined Metabolizer status was not able to be determined 0 None 0 3 0 3 View
Extensive Metabolizers Extensive metabolizer status was based on CYP2D6 sequence 0 None 0 54 5 54 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Anticholinergic adverse events SYSTEMATIC_ASSESSMENT Eye disorders None View